TI
ITCI

Turner Investments’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Turner Investments’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,400
Closed -$1.31M – 267
2015
Q4 		$1.31M Hold
24,400
– – 0.27% 109
2015
Q3 		$977K Buy
+24,400
New +$796K 0.2% 148

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Turner Investments's ITCI Position: Q1 2016 in Review

Turner Investments sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2016, closing a stake of 24,400 shares — an estimated $1.31M sold.

Turner Investments first reported a position in ITCI in Q3 2015 and held it in 2 quarters. The position peaked at $1.31M in Q4 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q1 2016.

  • Turner Investments reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2016 after selling out during the quarter.
  • Turner Investments sold 24,400 Intra-Cellular Therapies Inc. shares in Q1 2016, an estimated $1.31M.
  • Turner Investments first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 2 quarters.
  • Turner Investments's Intra-Cellular Therapies Inc. position peaked at $1.31M in Q4 2015.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.